Noncorticosteroidal anti-inflammatory agents in Ophthalmology.
Efforts have been made to develop noncorticosteroidal anti-inflammatory therapy. The goals of such therapy have been to eradicate the primary cause, prevent the initial tissue injury, moderate inflammatory response, and enhance tissue repair while minimizing and eliminating the undesirable aspects of the therapy.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001792:Blood Platelets / Q000187:drug effects; D005128:Eye Diseases / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000276:immunology; D008222:Lymphokines / Q000502:physiology; D010113:Oxyphenbutazone / Q000627:therapeutic use; D010653:Phenylbutazone / Q000627:therapeutic use; D011453:Prostaglandins / Q000502:physiology; D012459:Salicylates / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D008222:Lymphokines; D011453:Prostaglandins; D012459:Salicylates; D010653:Phenylbutazone; D010113:Oxyphenbutazone